subject area of
- An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis Academic Article
- Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: A qualitative systematic review Academic Article
- Endothelin-1 antagonism and nitric oxide augmentation prevents cyclosporine-induced vasomotor impairment Academic Article